New insights into mechanisms underlying nitrate tolerance

American Journal of Cardiology

Volumn 77, Issue 13, 1996, Pages C24-C30

  Münzel, Thomas ^a,b   Kurz, Sabine ^a   Heitzer, Thomas ^a   Harrison, David G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; ASCORBIC ACID; CALPHOSTIN C; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LINSIDOMINE; LOSARTAN; NEUROHORMONE; NORADRENALIN; ORGANIC NITRATE; PHENYLEPHRINE; PHORBOL DIBUTYRATE; POTASSIUM CHLORIDE; PROBUCOL; PROTEIN KINASE C INHIBITOR; SEROTONIN; STAUROSPORINE; SUPEROXIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

CONFERENCE PAPER; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; DRUG TOLERANCE; ENZYME INHIBITION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REBOUND; RECEPTOR BLOCKING; TRANSDERMAL DRUG ADMINISTRATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DRUG TOLERANCE; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; VASOCONSTRICTION;

EID: 0029889534     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00185-3     Document Type: Article

References (41)

1. Feelisch M, Noack E. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol 1987;142:465-469.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
3. Packer M, Lee W, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.
4. Elkayam U, Roth A, Kumar A, Kulick D, McIntosh N, McKay CR, Rahimtoola SH. Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation. Am J Cardiol 1987;60:1106-1111.
5. Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B, Fung HL. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988;77:1376-1384.
6. Abrams J. A reappraisal of nitrate therapy. JAMA 1988;259:396-401.
7. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 1991;114:667-677.
8. Dupuis J, Lalonde G, Lemieux R, Rouleau J. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol 1990;16:923-931.
9. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 1991;84:2336-2345.
10. Feelisch M, Keim M. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle cells and endothelial cells. Biochem Biophys Res Commun 1991;190:286-293.
11. Stewart DJ, Elsner D, Sommer O, Holtz J, Bassenge E. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation 1986;74:573-582.
12. Jeserich M, Münzel T, Pape L, Drexler H, Just H. Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease. J Am College Cardiol 1995;26:50-56.
13. Münzel T, Heitzer T, Kurz S, D.G. H, Luhmann C, L. P, Olschewski M, Just H. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin infusion in patients with coronary artery disease. J Am Coll Cardiol 1996;27:297-303.
14. Parker JD, Parker JO. Effects of therapy with an angiotensin converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. J Am Coll Cardiol 1993;1445-1453.
15. Slack CJ, McLaughlin BE, Brien JF, Marks GS, Nakatsu K. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates. Can J Physiol Pharmacol 1989;67:1381-1385.
16. Waldman SA, Rapoport RM, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 1986;35:3525-3531.
17. Axelsson KL, Andersson RG. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol 1983;88:71-79.
18. Needleman P, Johnson EMJ. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184:709-715.
19. Feelisch M, Keim M. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1991;180:286-293.
20. Forster S, Woditsch I, Schröder H, Schrör K. Reduced nitric oxide release causes nitrate tolerance in the intact circulation. J Cardiovasc Pharmacol 1991;17:867-872.
21. Münzel T, Holtz J, Mülsch A, Stewart D, Bassenge E. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation 1989;79:188-197.
22. Fung HL, Chong S, Kowaluk E, Hough K, Kakemi M. Mechanisms for the pharmacologic interaction of organic nitrates with thiols: existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine. J Pharmacol Exp Ther 1988;245:524-530.
23. Boesgard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A. Nitrate tolerance in vivo is not associated with depleteion of arterial or venous thiol levels. Circ Res 1994;74:115-120.
24. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 1987;76:577-584.
25. Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism of tolerance and cross tolerance. J Clin Invest 1995;95:187-194.
26. Molina CR, Andresen WA, Rapoport RM, Waldman S, Murad F. Effect of in vivo nitroglycerin therapy on endothelium dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 1987;10:371-378.
27. Rydell EL, Axelsson KL. Adrenaline toxicity in mice: sensitization of alpha 1 adrenoceptors by nitroglycerin. Acta Pharmacol Toxicol 1984;55:73-77.
28. Münzel T, Giaid A, Kurz S, Stewart D, Harrison D. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Nail Acad Sci USA 1995;92:5244-5248.
29. Andrea JE, Walsh MP. Protein kinase C of smooth muscle. Hypertension 1992;20:585-595.
30. Clozel M, Löffler BM, Breu V, Hilfiger L, Maire JP, Butscha B. Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 1993;265:C188-C192.
31. Lerman A, Edwards BS, Hallett JW, Heublin DM, Sandberg SM, Burnett JCJ. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
32. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart D. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-1739.
33. Heitzer T, Münzel T, Just H. Nitroglycerin induced hypersensitivity to vasoconstrictors is prevented by treatment with ACE-inhibitors. (Abstr.) Circulation 1995;92:1-18.
34. Münzel T, Kurz A, Rajagopalan S, Tarpey M, Freeman B, Harrison DG. Identification of the membrane bound NADH oxidase as the major source of superoxide anion in nitrate tolerance. (Abstr.) Endothelium 1995;3(suppl):S14.
35. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-1148.
36. Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle cells. J Pharmacol Exp Ther 1994;271:429-437.
37. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990;1:649-659.
38. Münzel T, Bassenge E. Chronic angiotensin converting enzyme inhibition with high dose enalapril retards nitrate tolerance and prevents coronary rebound constriction. Circulation 1996: (in press).
39. Kurz S, Münzel T, Harrison DG. A role for angiotensin II in nitrate tolerance: chronic AT-1 receptor blockade prevents development of tolerance and cross tolerance. (Abstr.) Circulation 1995;92:I-392.
40. Laight DW, Ànggard EE. Effects of antioxidants on tolerance to glyceryl trinitrate. (Abstr.) Endothelium 1995;3:S71.
41. Bassenge E, Fink B. Suppression of nitrate tolerance by vitamin C and other antioxidants. (Abstr.) Endothelium 1995;3:S71.